Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors.
We analysed 42 differentiated thyroid tumors including 15 follicular adenomas (FA), 13 papillary thyroid cancers (PTC) and 14 follicular thyroid carcinomas (FTC) with 13 microsatellite markers specific for the long arm of human chromosome 7 within 7q31; this region is deleted frequently in several other tumor types. Overall, 20 of the 42 samples analysed (48%) displayed LOH with one or more of the markers tested. LOH was detected most frequently (78%) in FTC, the most malignant of the thyroid tumors. A smallest common deleted region (SCDR) was defined in this tumor type flanked by markers D7S480 and D7S490. This SCDR is distinct from D7S522, the most commonly deleted locus in many other tumors, which was deleted in only one FTC. D7S522 did show LOH in two of six informative PTCs. None of the PTC and only two of the FAs showed LOH in the FTC SCDR. Since FA is considered a premalignant stage of FTC, our results suggest that inactivation of a putative tumor suppressor at 7q31.2 may be acquired during adenoma to carcinoma progression. The absence of LOH at this locus amongst PTC suggests that inactivation of this tumor suppressor is specific for FTC. In conclusion, LOH at 7q31 is a frequent event in differentiated thyroid cancer, and we have defined a 2 cM SCDR specific for FTC.
Department of Laboratory Medicine and Pathology, Mayo Foundation, Rochester, Minnesota 55905, USA.
J S
JS
Zhang
M
M
Nelson
B
B
McIver
I D
ID
Hay
J R
JR
Goellner
C S
CS
Grant
N L
NL
Eberhardt
D I
DI
Smith
D000236:Adenoma / Q000209:etiology / Q000235:genetics*; D018265:Carcinoma, Papillary, Follicular / Q000209:etiology / Q000235:genetics*; D002897:Chromosomes, Human, Pair 7 / Q000235:genetics*; D016147:Genes, Tumor Suppressor; D005819:Genetic Markers; D006801:Humans; D019656:Loss of Heterozygosity; D018895:Microsatellite Repeats; D013964:Thyroid Neoplasms / Q000209:etiology / Q000235:genetics*
D005819:Genetic Markers